| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.0091 | 0.8 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.0086 | 0.8 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.8 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.0089 | 0.8 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | -0.0091 | 0.8 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.009 | 0.8 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |